Induced Motion Illusions Through Vision and Tendon Vibrations: Study of Interactions in Hemiplegic Subjects (OPTIVIBE)

Two movement illusion techniques can currently be used in clinical practice for motor rehabilitation after stroke hemiplegia: visual illusion (mirror therapy) and proprioceptive illusion (tendon vibration). Mirror therapy, in its computerized version (IVS3, Dessintey, Saint-Etienne, France), is based on the substitution of the deficient visual feedback by a visual feedback of a correctly realized movement. The proprioceptive illusion is based on the external application of a vibrator on muscle tendons at a frequency between 50 and 120 Hz. These two techniques are currently used independently. They are, in theory, complementary and additive. No study has described the combinatorial properties of the illusions generated by these 2 techniques in hemiplegic subjects and healthy subjects.

Study Overview

Status

Terminated

Conditions

Detailed Description

The study hypothesis is that the administration of mirror therapy together with vibration will increase the perception of movement in a subjective scale.

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Étienne, France
        • CHU de Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Hemiplegic subjects :

  • Male or female
  • Aged 18 to 70 years,
  • First ischemic or hemorrhagic stroke causing hemiplegic
  • Having signed the written consent
  • Affiliated or entitled to a social security scheme

Healthy subjects :

  • Male or female, aged 18 to 70 years,
  • Matched in sex, age and laterally with hemiplegic subjects
  • Having signed the written consent
  • Affiliated or entitled to a social security scheme

Exclusion Criteria:

Hemiplegic subjects :

  • With complete lesion of the primary motor cortex
  • With an addiction to alcohol or drugs
  • With psychiatric illness, cognitive impairment, uncontrolled disease/epilepsy, malignant illness severe kidney or lung disease
  • With history of associated general disabling disease
  • With cerebellar syndrome
  • With clinical brain stem involvement
  • Under legal protection
  • Pregnant or breastfeeding women

Healthy subjects :

  • Neurological, cardiovascular, musculoskeletal diseases
  • Taking medication that can affect attention
  • Unable to understand instructions of the study
  • Under legal protection
  • Pregnant or breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient with first stroke causing hemiplegic

Patient with first stroke causing hemiplegic will be included.

They will have Computerized Mirror Therapy (CMT) associated at tendon vibration:

  • Visit 1: wrist flexion (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of extension+vibration(incongruence))
  • Visit 2 (1 week later): wrist extension (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of flexion+vibration (incongruence)) These conditions will be recording by the Kinovea software, which allows the measurement of angles and amplitudes.

Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3).

The patient looks on a screen in front of him, mirroring the movements made by his hand, while attempting to perform the same movement with his other hand.

Other Names:
  • Intensive Visual Simulation3 (IVS3), Dessintey, Saint Etienne, France
Transcutaneous vibrations are used. This device allows vibrations from 50 to 120 Hz with amplitude of 1 mm. This study the frequency used is 70 and 80 Hz.
Other Names:
  • Vibrasens, VB115, Techno Concept, France
Sham Comparator: healthy subjects

Healthy subjects will be included.

They will have Computerized Mirror Therapy (CMT) associated at tendon vibration:

  • Visit 1: wrist flexion (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of extension+vibration(incongruence))
  • Visit 2 (1 week later): wrist extension (right and left arms) with 5 randomized experimental conditions (vision+vibration, vision alone, vibration alone, static image+vibration, vision of flexion+vibration (incongruence)) These conditions will be recording by the Kinovea software, which allows the measurement of angles and amplitudes.

Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3).

The patient looks on a screen in front of him, mirroring the movements made by his hand, while attempting to perform the same movement with his other hand.

Other Names:
  • Intensive Visual Simulation3 (IVS3), Dessintey, Saint Etienne, France
Transcutaneous vibrations are used. This device allows vibrations from 50 to 120 Hz with amplitude of 1 mm. This study the frequency used is 70 and 80 Hz.
Other Names:
  • Vibrasens, VB115, Techno Concept, France

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
subjective measure of the intensity of the perception of movements: change from baseline impression of movement at day 7
Time Frame: Day: 0, 7
Measured impression of movement on conditions (visual and/or proprioceptive; yes/no/don't know)
Day: 0, 7
subjective measure of the intensity of the perception of movements: change from baseline nature of this impression at day 7
Time Frame: Day: 0, 7
Measured nature of this impression of movement (flexion/extension)
Day: 0, 7
subjective measure of the intensity of the perception of movements: change from baseline intensity of the movement felt at day 7
Time Frame: Day: 0, 7
Measured intensity of the movement felt by Visual Analogue Scale (VAS) results (0 = no sense of movement and 10 = like real movement.)
Day: 0, 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective measurement of the perceived movement angle reproduced without motor intention by the hemiplegic subjects with the healthy limb
Time Frame: Day: 0, 7
Measured by Kinovea software.
Day: 0, 7
Measurement of motor intention in hemiplegic subjects by experimental conditions
Time Frame: Day: 0, 7
Measured by Visual Analogue Scale (VAS) results (0 = no sense of movement and 10 = like real movement).
Day: 0, 7
To compare the Visual Analogue Scale (VAS) score according to the level of motor impairment
Time Frame: Day: 0
Level of motor impairment is measured by Medical Research Council (MRC) score. Medical Research Council (MRC) score evaluate motricity (0= paralyzed).
Day: 0
To compare the Visual Analogue Scale (VAS) score with the Erasmus modified Nottingham Sensory Assessment (EmNSA) score
Time Frame: Day: 0

Erasmus modified Nottingham Sensory Assessment (EmNSA) score evaluated the level of sensory impairment.

The Erasmus modified Nottingham Sensory Assessment (EmNSA) includes 2 subscales: somatosensory score (min 0 and max 44) and stereognosis (min 0 and max 20) for left and right members.

Day: 0
Intensity of the perception of movements using a visual analogue scale and the objective measurement of perceived movement angle reproduced by the healthy subjects with the vibrated arm
Time Frame: Day: 0, 7
Measured by Kinovea software.
Day: 0, 7
Brain activity according to different experimental conditions (with and without vibration or with and without visual illusion) in hemiplegic subjects.
Time Frame: Day: 0, 7
Multi Channel EEG Acquisition System
Day: 0, 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pascal GIRAUX, PhD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2021

Primary Completion (Actual)

April 25, 2023

Study Completion (Actual)

April 28, 2023

Study Registration Dates

First Submitted

June 22, 2020

First Submitted That Met QC Criteria

June 25, 2020

First Posted (Actual)

June 26, 2020

Study Record Updates

Last Update Posted (Actual)

May 30, 2023

Last Update Submitted That Met QC Criteria

May 26, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegia

Clinical Trials on Computerized Mirror Therapy (CMT)

Subscribe